Pathway

Inflammatory alarm

NLRP3 Inflammasome

The Sterile Alarm

13 blends on this site modulate it.

Also searched as NLRP3 Inflammasome.

You want it calmed: quieting chronic NLRP3 firing lowers the smoldering inflammation of aging.

In depth

The NLRP3 inflammasome — a sensor of cellular stress that ignites sterile, damage-driven inflammation.

What drives it

Ketone fuel reduces it.

Youm 2015, Nat Med 21:263 — the ketone β-hydroxybutyrate suppresses NLRP3 inflammasome activation (blocking K+ efflux and ASC oligomerization), linking fasting to reduced inflammation. doi 10.1038/nm.3804

Calms inflammation increases it.

Bauernfeind 2009, J Immunol 183:787 — NF-κB licenses NLRP3 by inducing its expression (priming step). PMID 19570822. The word 'license' is doing precise work and the atlas should not blur it: NLRP3 has a two-signal requirement. NF-kappa-B supplies signal 1 only — priming, i.e. transcriptional induction of NLRP3, pro-IL-1-beta and pro-IL-18 downstream of TLR4 or TNF receptor signaling. Signal 2, the actual assembly, requires a separate stimulus: PAMPs and DAMPs including extracellular ATP, pore-forming toxins, RNA viruses and particulate matter (PMC8093260). NF-kappa-B makes the inflammasome possible; it does not fire it. Necessary, not sufficient. And transcriptional priming is not the only route: NLRP3 can be primed non-transcriptionally by a short LPS pulse via phosphorylation, de-phosphorylation, de-ubiquitination and de-sumoylation; transgenic NLRP3 expression bypasses the transcriptional priming requirement entirely — which confirms NF-kappa-B's contribution is at the level of expression, not activation. Species: the NEK7-dependence work is mainly murine; human myeloid cells were shown to activate NLRP3 by a NEK7-independent route. PMID 19570822 · PMC8093260

Gut-brain signal reduces it.

The founding experiment is a cut and a current: transection of the vagus in rats subjected to LPS-induced endotoxaemia led to a more aggressive systemic inflammatory response, characterized by earlier onset of shock and higher serum and liver TNF-alpha. And electrical stimulation of the distal arm of the transected vagus attenuated this response. Stimulating the cut end proves the signal runs outward — the brain is not merely being informed of inflammation, it is switching it off. And the receptor is proven necessary by genetics, not inferred: electrical stimulation significantly attenuated endotoxin-induced serum TNF in wild-type mice. Vagus nerve stimulation in alpha-7 nicotinic acetylcholine receptor deficient mice, however, failed to reduce serum TNF. Same stimulation, same endotoxin, one missing subunit, no effect. The cellular route is stranger than a nerve-to-macrophage synapse and worth knowing: the acetylcholine is produced by choline-acetyltransferase-positive T cells, which act on macrophages expressing alpha-7 receptors. A nerve talks to a lymphocyte and the lymphocyte makes the neurotransmitter. And SPLENECTOMY inactivates the pathway — the spleen is the effector organ. Why this arrow points at the inflammasome specifically: alpha-7 nicotinic acetylcholine receptor signaling inhibits inflammasome activation by preventing mitochondrial DNA release. That is the precise molecular target, and the NLRP3 inflammasome already reaches neuroinflammation and atherosclerosis on the map — so this link connects the gut-brain axis to the CHIP/atherosclerosis mechanism through a shared node neither review was looking for. It reaches clinic: vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis, with trials extending to lupus, gout and inflammatory bowel disease. the mechanistic work is rodent; the clinical work is open-label or small-trial. The Borovikova and Wang findings are cited from the primary literature. doi 10.1073/pnas.1605635113 · PMC9381415

TCA metabolite increases it.

Via the IL-1-beta arm. Carried by the intermediary-metabolism, micronutrient and redox reviews. doi 10.3390/nu18132141 · PMC9967593

Eases ER stress increases it.

A named molecular route rather than an association: IRE1-alpha degrades miR17, TXNIP rises unchecked, and the NLRP3 inflammasome activates. doi 10.1016/j.jhep.2018.06.008 · PMC4100367

Immunotherapy heart inflammation increases it.

The same self-antigen, reached by a completely different road. 'Mechanistic studies further implicate autoreactive T cells targeting cardiac α-MYOSIN heavy chain (α-MyHC), a contractile protein uniquely expressed in cardiac muscle, as central mediators... In preclinical models, immunization with α-MyHC peptides induces autoimmune myocarditis' (pmc12698404 · doi 10.3389/fimmu.2025.1677984 — Overview of immune checkpoint inhibitor associated myocarditis mechanisms diagnostics and treatment). ⇒ this is the exact protein used to create the laboratory autoimmune model. A virus can expose it, a cancer drug can unmask it, and a syringe can inject it — and the heart suffers the same way in all three cases. The downstream is shared too: 'dual blockade of PD-1 and CTLA-4 induces a pro-inflammatory phenotype in cardiac tissues through upregulation of NF-κB, NLRP3 inflammasome components, and MyD88'. doi 10.3389/fimmu.2025.1677984

Coxsackievirus B3 increases it.

10.1038/s41598-018-20686-6 — this one was confirmed in actual human hearts, not only in mice. 'The presence of the NLRP3 inflammasome has been shown in endomyocardial biopsies of patients with acute myocarditis' (ScienceDirect Topics — Coxsackievirus B3 overview (citing Toldo et al. 2014; Wang, Gao & Xiong 2014; Wang et al. 2018)). Most of what is known about this illness comes from animals — this step was found in tissue taken from living patients. And the chain is timed: 'Infection with coxsackievirus B3... is associated with enhanced NLRP3 activation together with increased ASC, caspase-1 and IL-1β expression observed within 7 days from the infection in mice.'. doi 10.1038/s41598-018-20686-6

Lysosomal protease increases it.

PMID 32328491 — A different kind of dying. Ordinary programmed cell death is quiet and tidy — the cell folds itself away. This one bursts, spilling its contents and inflaming everything around it. And the trigger is named: 'in experimental CVB3-induced myocarditis, inflammasome activation and subsequent pyroptosis seem to be mediated by cathepsin B' (ScienceDirect Topics — Coxsackievirus B3 overview (citing Toldo et al. 2014; Wang, Gao & Xiong 2014; Wang et al. 2018)). ⇒ that is why this illness amplifies itself: every cell that dies this way recruits more inflammation to kill the next one. PMID 32328491

Viral replication increases it.

A second virus, the same machinery. 'The emcv 2B protein induces the efflux of Golgi Ca2+ from dendritic cells and macrophages, activates the NLRP3 inflammasome and caspase-1, and facilitates the proteolytic conversion of pro-IL-1β into mature IL-1β' (doi 10.3389/fphar.2026.1865874 — Curcumol alleviates cardiac and cerebral injury caused by encephalomyocarditis virus (emcv) in Kunming mice via suppressing nf-κB/NLRP3 inflammasome pathway). ⇒ a different picornavirus, reaching the same inflammasome this MAP already draws from coxsackievirus. the convergence is the point: the heart has a limited number of ways to be damaged, and different viruses find the same ones. doi 10.3389/fphar.2026.1865874

What it drives

It increases Brain inflammation.

Microglial NLRP3 study 2018 — NLRP3 inflammasome activates caspase-1 → IL-1β, driving neuroinflammation and neuronal loss. PMID 29786072

It increases Arterial plaque.

The population fact: CLONAL hematopoiesis of indeterminate potential affects over 10 percent of individuals older than 70 and confers A 1.5- to 2-fold increased risk of coronary heart disease and all-cause mortality, independent of traditional cardiovascular risk factors. Independent of the traditional factors is the phrase that makes this a separate driver rather than a restatement of the lipid arm. The mouse work names the mechanism: bone marrow reconstitution with TET2-deficient cells increases atherosclerotic plaque size, an effect mediated by NLRP3 inflammasome activation and downstream increases in interleukin-1-beta and interleukin-6. And then the human confirmation, which is the best thing on this pathway: in an exploratory analysis of the CANTOS trial, patients with TET2 CHIP had reduced major adverse cardiovascular event rates when treated with a monoclonal antibody neutralizing IL-1-beta. The mouse mechanism did not merely describe something — it predicted which humans would respond to a drug, and the prediction held in a 10,061-patient randomized trial. Two mutations, two inflammatory profiles, two different drug responses, matching. A paradox recorded rather than smoothed: Jak2-V617F is an activating mutation associated with over a 12-fold increase in incident coronary events — yet deletion of Jak2 in various cell types also paradoxically leads to increased atherosclerosis. Gain and loss of function in the same kinase both make it worse, which no simple sign accommodates. The atlas can express the inflammasome but not the somatic clonal expansion upstream of it, so this edge carries the mechanism while the cause sits outside the map. doi 10.1016/j.jaccao.2025.05.013 · PMC11058018

It increases Cellular aging.

C. acnes promotes inflammation via TLR2 and TLR4; TLR signals induce NF-kB-dependent expression of NLRP3, pro-IL-18 and pro-IL-1beta. Androgens raise sebum secretion, triggering acne. doi 10.21037/atm-22-1362 · PMC2904443

It reduces Immune balance.

Named across five inflammaging and hallmarks-of-aging reviews as part of the shared mechanism set that links molecular damage to organ decline: nutritional perception dysregulation and inflammatory aging ARE the core key elements linking upstream molecular damage to downstream organ function decline. doi 10.1016/j.molmet.2023.101755 · PMC11233824

It reduces Heart & blood pressure.

It increases Joint wear.

It increases Neurovascular calm.

It increases Calms body-wide inflammation.

It increases Urate clearance.

It reduces Joint comfort.

10.1038/s41413-026-00573-x — The aging outcome lists the thirteen hallmarks themselves, each mapped to its pathway and labeled with its hallmark number. (from the reviews of this outcome). Verbatim: “Accumulating evidence indicates that nod-like receptor pyrin domain 3 (NLRP3) inflammasome-mediated pyroptosis of chondrocytes plays a crucial role in the OA progression”. doi 10.1038/s41413-026-00573-x · PMID 37506502

It increases Calm pain signaling.

It increases Clear skin.

It increases Heart muscle inflammation.

How the body first notices — and why noticing is not harmless. 'release of PAMPs and DAMPs activates innate immune pathways' (Heart Failure Reviews 2026, doi 10.1007/s10741-026-10654-y), which run through the same master inflammatory switch that drives the inflammatory response. ⇒ the alarm that detects the virus is the same alarm that, left on, damages the muscle. That is why the second phase is the dangerous one. doi 10.1007/s10741-026-10654-y

It increases Inflammatory protease.

PMID 32328491 — this one was confirmed in actual human hearts, not only in mice. 'The presence of the NLRP3 inflammasome has been shown in endomyocardial biopsies of patients with acute myocarditis' (ScienceDirect Topics — Coxsackievirus B3 overview (citing Toldo et al. 2014; Wang, Gao & Xiong 2014; Wang et al. 2018)). Most of what is known about this illness comes from animals — this step was found in tissue taken from living patients. And the chain is timed: 'Infection with coxsackievirus B3... is associated with enhanced NLRP3 activation together with increased ASC, caspase-1 and IL-1β expression observed within 7 days from the infection in mice.'. PMID 32328491